共 50 条
- [41] Elimination and Degradation of Glucagon-like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Patients with End-Stage Renal Disease JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (07): : 2457 - 2466
- [45] Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on β-cell secretion and insulin clearance in mice METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (07): : 988 - 992
- [46] Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer's and Parkinson's diseases FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2022, 14
- [47] Targeting central pathway of Glucose-Dependent Insulinotropic Polypeptide, Glucagon and Glucagon-like Peptide-1 for metabolic regulation in obesity and type 2 diabetes DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1660 - 1675
- [49] Calcium co-ingestion augments postprandial glucose-dependent insulinotropic peptide1–42, glucagon-like peptide-1 and insulin concentrations in humans European Journal of Nutrition, 2014, 53 : 375 - 385